[Antiplatelet drugs as a means of augmentation efficacy and safety of percutaneous coronary interventions in patients with ischemic heart disease].
Averkov
O V
OV
Laboratory of Clinical Cardiology Research, Institute for Physiochemical Medicine, Moscow, Russia.
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D003328:Coronary Thrombosis / Q000517:prevention & control*; D006801:Humans; D017202:Myocardial Ischemia / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D010975:Platelet Aggregation Inhibitors